JP2025503177A5 - - Google Patents
Info
- Publication number
- JP2025503177A5 JP2025503177A5 JP2024544414A JP2024544414A JP2025503177A5 JP 2025503177 A5 JP2025503177 A5 JP 2025503177A5 JP 2024544414 A JP2024544414 A JP 2024544414A JP 2024544414 A JP2024544414 A JP 2024544414A JP 2025503177 A5 JP2025503177 A5 JP 2025503177A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- day
- bispecific antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263304422P | 2022-01-28 | 2022-01-28 | |
| US63/304,422 | 2022-01-28 | ||
| PCT/EP2023/052005 WO2023144306A1 (en) | 2022-01-28 | 2023-01-27 | Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503177A JP2025503177A (ja) | 2025-01-30 |
| JP2025503177A5 true JP2025503177A5 (https=) | 2026-02-10 |
Family
ID=85158380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544414A Pending JP2025503177A (ja) | 2022-01-28 | 2023-01-27 | びまん性大細胞型ｂ細胞リンパ腫を治療するための併用療法におけるｃｄ３及びｃｄ２０に対する二重特異性抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230303693A1 (https=) |
| EP (1) | EP4469083A1 (https=) |
| JP (1) | JP2025503177A (https=) |
| KR (1) | KR20240144239A (https=) |
| CN (1) | CN118647402A (https=) |
| AU (1) | AU2023213099A1 (https=) |
| CA (1) | CA3243347A1 (https=) |
| IL (1) | IL314341A (https=) |
| MX (1) | MX2024008832A (https=) |
| TW (1) | TW202345905A (https=) |
| WO (1) | WO2023144306A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022013797A (es) | 2020-05-08 | 2022-11-30 | Genmab As | Anticuerpos biespecificos contra cd3 y cd20. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| GB9203459D0 (en) | 1992-02-19 | 1992-04-08 | Scotgen Ltd | Antibodies with germ-line variable regions |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| ATE299938T1 (de) | 1997-05-02 | 2005-08-15 | Genentech Inc | Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen |
| BRPI0315295C1 (pt) | 2002-10-17 | 2021-05-25 | Genmab As | anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão |
| US7741568B2 (en) | 2005-01-13 | 2010-06-22 | The Wiremold Company | Downward facing receptacle assembly for cable raceway |
| AU2006232287B2 (en) | 2005-03-31 | 2011-10-06 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
| CA2631184A1 (en) | 2005-11-28 | 2007-05-31 | Genmab A/S | Recombinant monovalent antibodies and methods for production thereof |
| JP6157046B2 (ja) | 2008-01-07 | 2017-07-05 | アムジェン インコーポレイテッド | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 |
| WO2010129304A2 (en) | 2009-04-27 | 2010-11-11 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| AR080794A1 (es) | 2010-03-26 | 2012-05-09 | Hoffmann La Roche | Anticuerpos bivalentes biespecificos anti- vegf/ anti-ang-2 |
| HRP20241208T1 (hr) | 2010-04-20 | 2024-11-22 | Genmab A/S | Heterodimerni proteini koji sadrže fc fragment protutijela i postupci za njihovu proizvodnju |
| SG11201401422VA (en) | 2011-10-27 | 2014-09-26 | Genmab As | Production of heterodimeric proteins |
| ME03675B (me) | 2013-07-05 | 2020-10-20 | Genmab As | Humanizovana ili himerna anтi-cd3 antiтela |
| US10544220B2 (en) | 2015-01-08 | 2020-01-28 | Genmab A/S | Bispecific antibodies against CD3 and CD20 |
| CN111787948A (zh) | 2018-02-09 | 2020-10-16 | 健玛保 | 包含针对cd3和cd20的双特异性抗体的药物组合物及其用途 |
| US20240034812A1 (en) * | 2020-09-10 | 2024-02-01 | Genmab A/S | Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphoma |
-
2023
- 2023-01-27 CN CN202380019130.7A patent/CN118647402A/zh active Pending
- 2023-01-27 MX MX2024008832A patent/MX2024008832A/es unknown
- 2023-01-27 CA CA3243347A patent/CA3243347A1/en active Pending
- 2023-01-27 US US18/160,391 patent/US20230303693A1/en active Pending
- 2023-01-27 EP EP23702969.9A patent/EP4469083A1/en active Pending
- 2023-01-27 KR KR1020247028132A patent/KR20240144239A/ko active Pending
- 2023-01-27 AU AU2023213099A patent/AU2023213099A1/en active Pending
- 2023-01-27 IL IL314341A patent/IL314341A/en unknown
- 2023-01-27 US US18/833,267 patent/US20250101102A1/en active Pending
- 2023-01-27 JP JP2024544414A patent/JP2025503177A/ja active Pending
- 2023-01-27 WO PCT/EP2023/052005 patent/WO2023144306A1/en not_active Ceased
- 2023-01-30 TW TW112103162A patent/TW202345905A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541860A5 (https=) | ||
| JP2023542289A5 (https=) | ||
| JP2023542290A5 (https=) | ||
| JP2023541858A5 (https=) | ||
| JP2023517236A5 (https=) | ||
| JP2023524149A5 (https=) | ||
| JP2023542092A5 (https=) | ||
| JP2023542291A5 (https=) | ||
| JP2023002615A5 (https=) | ||
| JP2021501162A5 (https=) | ||
| JP6278536B2 (ja) | 関節炎治療 | |
| CA2478049A1 (en) | Humanized antibodies that recognize beta amyloid peptide | |
| RU2017121327A (ru) | Комбинированная терапия на основе активирующих т-клетки биспецифических антигенсвязывающих молекул против cd3 и фолатного рецептора 1 (folr1) и антагонистов, связывающихся с осью pd-1 | |
| JP2025032102A5 (https=) | ||
| IL255552A (en) | Treatment of multiple myeloma | |
| JP2022512875A5 (https=) | ||
| JP2019517540A5 (https=) | ||
| JP2021512107A5 (https=) | ||
| JP2024534602A5 (https=) | ||
| JP2024069230A5 (https=) | ||
| WO2017059813A1 (zh) | 抗乙肝表面抗原的抗体及其用途 | |
| JP2025508317A5 (https=) | ||
| JP2024527401A5 (https=) | ||
| JP2025503177A5 (https=) | ||
| JP2020505350A5 (https=) |